The Quest for Understanding Diabetic Cardiomyopathy: Can We Preserve Function and Prevent Failure?

Competing Interests: Funding Support and Author Disclosures Dr Lala has served on advisory boards for Boehringer Ingelheim and Novo Nordisk; has received research grants from AstraZeneca and Merck; and has received speaker honoraria from Zoll. Dr Santos-Gallego is partially supported by the Robert A. Winn Career Development Award; has received research grants from Merck; and has served on advisory boards for Novo Nordisk. Dr Mentz has reported that he has no relationships relevant to the contents of this paper to disclose.